
C Light Technologies Inc (AKA: C. LIGHT TECHNOLOGIES, INC. ) Profile last edited on: 4/7/2018
CAGE: 790C0
UEI: FKBJC9XK16F8
Business Identifier: Optics, Biomedical Imaging Devices, Eye-tracking, Neurodegeneration Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
1771 Highland Place Suite 8
Berkeley, CA 94709
Berkeley, CA 94709
Location: Single
Congr. District: 13
County: Alameda
Congr. District: 13
County: Alameda
Public Profile
C. Light Technologies, Inc. is a biomedical device start-up company focused on the further development and expansion of the tracking laser scanning ophthalmoscope (TSLO) - a non-invasive, precision eye-tracking technology with single-cell light delivery capabilities. With Eye-tracking a factor used to monitor neurological health in many disorders, C.Light is focused to the use of the firm's technology and method for artifact-free eye-tracking in a system that is low cost, robust, and easy to use. The system is accurate, fast and functional eye-tracking system and can be used in a standard ophthalmic instrument. The C. Light system is capable of tracking the eye at 960Hz, with an accuracy of 0.2arcmin. Management plan to make the TSLO more widely available to researchers/academics while ultimately preparing this product for the clinical domain. The most commonly used current tracking technologies employ the use of video-based eye-tracking methods, many of which have an accuracy of 30 arcminutes, or roughly half a degree, and are very expensive. While sufficient for gaze detection, this level of inaccuracy is unacceptable for minute eye movement tracking, disease progression monitoring, and surgical laser guidance. .
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
5-9Revenue Range
.5M-1MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2023 | 2 | NIH | $2,400,083 | |
Project Title: Retinal eye-tracking as a diagnostic tool for traumatic brain injury and concussion. | ||||
2018 | 1 | NIH | $225,392 | |
Project Title: Retinal Eye-Tracking for the Prognosis and Monitoring of Multiple Sclerosis |
Key People / Management
Christy K Sheehy -- Founder and CEO
Zach Helft -- Founder
Andrew Norton
Zach Helft -- Founder
Andrew Norton
Company News
There are no news available.